Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Østergaard

Showing results (201-210 of 403) with videos related to

Pageof 41
Sort By:
Arthritis Care & Research|September 12, 2019
Sustained Long-Term Efficacy of Motivational Counseling and Text Message Reminders on Daily Sitting Time in Patients With Rheumatoid Arthritis: Long-Term Follow-up of a Randomized, Parallel-Group TrialTanja Thomsen, Mette Aadahl, Nina Beyer, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI ScorePhilip Conaghan, Marissa Lassere, Mikkel Østergaard, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring systemMikkel Østergaard, Charles Peterfy, Philip Conaghan, et al.
The Journal of Rheumatology|December 2, 2021
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 YearsDésirée van der Heijde, Mikkel Østergaard, John D Reveille, et al.
Rheumatology (Oxford, England)|February 21, 2022
Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imagingWalter P Maksymowych, Rebecca Bolce, Gaia Gallo, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
Arthritis and Rheumatism|September 12, 2013
M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritisChristian G Ammitzbøll, Steffen Thiel, Jens C Jensenius, et al.
Annals of the Rheumatic Diseases|December 16, 2016
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trialsCharles Peterfy, Vibeke Strand, Lu Tian, et al.
Current Medical Research and Opinion|February 20, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesJeffrey R Curtis, Cecilie H Brahe, Mikkel Østergaard, et al.
RMD Open|March 21, 2018
Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trialSimon Krabbe, Inge J Sørensen, Bente Jensen, et al.
Pageof 41

Showing results (201-210 of 403) with videos related to

Sort By:
Pageof 41
Arthritis Care & Research|September 12, 2019
Sustained Long-Term Efficacy of Motivational Counseling and Text Message Reminders on Daily Sitting Time in Patients With Rheumatoid Arthritis: Long-Term Follow-up of a Randomized, Parallel-Group TrialTanja Thomsen, Mette Aadahl, Nina Beyer, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI ScorePhilip Conaghan, Marissa Lassere, Mikkel Østergaard, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring systemMikkel Østergaard, Charles Peterfy, Philip Conaghan, et al.
The Journal of Rheumatology|December 2, 2021
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 YearsDésirée van der Heijde, Mikkel Østergaard, John D Reveille, et al.
Rheumatology (Oxford, England)|February 21, 2022
Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imagingWalter P Maksymowych, Rebecca Bolce, Gaia Gallo, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
Arthritis and Rheumatism|September 12, 2013
M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritisChristian G Ammitzbøll, Steffen Thiel, Jens C Jensenius, et al.
Annals of the Rheumatic Diseases|December 16, 2016
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trialsCharles Peterfy, Vibeke Strand, Lu Tian, et al.
Current Medical Research and Opinion|February 20, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesJeffrey R Curtis, Cecilie H Brahe, Mikkel Østergaard, et al.
RMD Open|March 21, 2018
Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trialSimon Krabbe, Inge J Sørensen, Bente Jensen, et al.
Pageof 41